NIH Halts Clinical Trial of Hydroxychloroquine

June 23, 2020 by Christen Aldrich

Filed under COVID-19 for Employers, COVID-19 for the Workforce

Last modified June 24, 2020

A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus has been stopped by the National Institutes of Health. A media advisory was just released, with a data and safety monitoring board (DSMB) meeting late Friday and determining that while there was no harm, the study drug was very unlikely to be beneficial to hospitalized patients with COVID-19.

Share this

Related Articles

                                Leave a Comment